Core & Main, Inc. Class A CNM 深 沪
交易中 04-01 10:43:37 美东时间
50.56
+1.160
+2.35%
华盛通- 最 高51.085
- 今 开49.76
- 成交量 37.63万股
- 最 低 49.71
- 昨 收 49.40
- 总市值 98.42亿
- 52周最高 67.18
- 市盈率 静 21.89
- 换手率 0.19%
- 52周最低 43.96
- 委 比 92.20%
- 总股本 1.95亿
- 历史最高 67.18
- 量 比 0.96
- 振 幅 2.78%
- 历史最低 18.75
- 每 手 1
- 风险率 5.54%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Core & Main Executive Chair Stephen LeClair Retires; James Castellano Appointed Chair
Core & Main, Inc. (NYSE:CNM), a leading specialty distributor dedicated to advancing reliable infrastructure with local service, nationwide, today announced changes to its board of directors and executive chair,
03-28 04:16
美股大行评级 | 最高240美元，潜在涨幅53%！ARM获多家大行上调目标价；Braze 评级上演 “两极反转”，小摩、巴克莱上调，高盛、花旗下调
今日重点评级关注：HC Wainwright & Co.：维持OCUGEN"买入"评级，目标价从7美元升至10美元；HC Wainwright & Co.：维持Maze Therapeutics"买入"评级，目标价从60美元升至110美元
03-26 11:41
财报速睇 | Core & Main, Inc. Class A 2026财年Q1营收15.81亿美元，同比下降6.9%；归母净利润0.70亿美元，同比增长9.4%
华盛资讯3月24日讯，Core & Main, Inc. Class A公布2026财年Q1业绩，公司Q1营收15.81亿美元，同比下降6.9%，归母净利润0.70亿美元，同比增长9.4%。
03-24 19:47
Earnings Scheduled For March 24, 2026
Companies Reporting Before The Bell • Fennec Pharmaceuticals (NASDAQ:FENC) is e...
03-24 19:11
Top Wall Street Forecasters Revamp Core & Main Expectations Ahead Of Q4 Earnings
Core & Main, Inc. (NYSE: CNM) will release Q4 earnings on March 24. Analysts expect EPS of 42 cents and revenue of $1.6 million. Stock fell 0.4%.
03-20 20:47
Alpha Buying: Learning From a Research-Driven Hedge Fund
Every now and then a hedge fund manager appears who reminds us that despite all...
03-12 22:31
美股大行评级 | 英特尔、美光科技、SanDisk等获大行上调目标价；纽约梅隆银行获5家大行上调目标价
今日重点评级关注：HC Wainwright & Co.：维持Rezolve AI"买入"评级，目标价从10美元升至12美元；HC Wainwright & Co.：维持Largo"买入"评级，目标价从2.9美元升至3.1美元
01-15 16:10
Wells Fargo Maintains Overweight on Core & Main, Raises Price Target to $65
Wells Fargo analyst Sam Reid maintains Core & Main (NYSE:CNM) with a Overweight and raises the price target from $57 to $65.
01-14 23:46
美股大行评级 | 潜在涨幅197.4%！奥麦罗制药获HC Wainwright升目标价至40美元，维持"买入"评级
今日重点评级关注：HC Wainwright & Co.：维持奥麦罗制药"买入"评级，目标价从20美元升至40美元；HC Wainwright & Co.：维持Cullinan Therapeutics"买入"评级，目标价从26美元升至27美元
01-09 20:22
Core & Main Strikes Agreement To Acquire Pioneer Supply; Financial Terms Not Disclosed
Core & Main Inc. (NYSE: CNM), a leader in advancing reliable infrastructure with local service, nationwide, has entered into a definitive agreement to acquire Pioneer Supply, a distributor of water, wastewater and
01-06 05:16
